DAKLINZA

Product NDC
0003-0011
11-digit product format
000030011
Labeler code
0003
Product ID
0003-0011_780ae42b-9b05-4a02-9529-5e45dbb460f6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
daclatasvir
Dosage form
TABLET
Route
ORAL
Labeler
E.R. Squibb & Sons, L.L.C.
Application
NDA206843
Marketing category
NDA
Marketing start
2016-05-18
Marketing end
2019-04-30
Substance
DACLATASVIR DIHYDROCHLORIDE
Active strength
90 mg/1
Pharmacologic classes
Hepatitis C Virus NS5A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0003-0011-01EA - Each0003-0011c20a3c03-0283-42cf-93ac-e3d2491ac57e12016-06-14